TenX Keane Acquisition Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Xiaofeng Yuan

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	2.9yrs
Participación del CEO	n/a
Permanencia media de la dirección	sin datos
Promedio de permanencia en la Junta Directiva	sin datos

Actualizaciones recientes de la dirección

Recent updates

CEO

Xiaofeng Yuan (52 yo)

2.9yrs

Permanencia

Mr. Xiaofeng Yuan has been Executive Director and Chairman of TenX Keane Acquisition Corp. since March 2021 and also serves as its Chief Executive Officer since July 2021. Mr. Yuan founded 38Fule Group and...

TenX Keane Acquisition Dirección

Dirección controles de criterios 0/4

Información clave

Actualizaciones recientes de la dirección

Insufficient new directors

Recent updates

TenX Keane Acquisition announced delayed 10-Q filing

TenX Keane Acquisition announced delayed annual 10-K filing

Insufficient new directors

TenX Keane Acquisition announced that it has received $0.2 million in funding

TenX Keane Acquisition announced delayed 10-Q filing

Citius Oncology, Inc. entered into an agreement and plan of merger to acquire TenX Keane Acquisition (NasdaqGM:TENK) from 10XYZ Holdings LP and others for approximately $730 million in a reverse merger transaction.

Citius Oncology, Inc. entered into an agreement and plan of merger to acquire TenX Keane Acquisition (NasdaqGM:TENK) from 10XYZ Holdings LP and others for approximately $730 million in a reverse merger transaction.

TenX Keane Acquisition announced that it has received $0.66 million in funding from 10XYZ Holdings LP

TenX Keane Acquisition announced delayed 10-Q filing

CEO

Permanencia